The document discusses scales used to measure dyspnea in patients with chronic respiratory diseases. It describes the Borg scale and modified Borg dyspnea scale, which allow patients to subjectively rate their level of exertion. It also describes the mMRC dyspnea scale, which measures perceived respiratory disability by having patients indicate how breathlessness affects their mobility. These scales are useful for clinicians to quantify dyspnea, describe disability levels, and assess changes after treatment. Pulmonary rehabilitation can help reduce dyspnea through various mechanisms like improving muscle function, reducing ventilatory impedance, and decreasing central drive.
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
Gas exchange between the alveoli and the pulmonary capillary blood occurs by diffusion, as will be discussed in the next chapter. Diffusion of oxygen and carbon dioxide occurs passively, according to their concentration differences across the alveolar-capillary barrier. These concentration differences must be maintained by ventilation of the alveoli and perfusion of the pulmonary capillaries.
Alveolar ventilation brings oxygen into the lung and removes carbon dioxide from it. Similarly, the mixed venous blood brings carbon dioxide into the lung and takes up alveolar oxygen. The alveolar Image not available. and Image not available. are thus determined by the relationship between alveolar ventilation and pulmonary capillary perfusion. Alterations in the ratio of ventilation to perfusion, called the Image not available., will result in changes in the alveolar Image not available. and Image not available., as well as in gas delivery to or removal from the lung.
Alveolar ventilation is normally about 4 to 6 L/min and pulmonary blood flow (which is equal to cardiac output) has a similar range, and so the Image not available. for the whole lung is in the range of 0.8 to 1.2. Image not available. However, ventilation and perfusion must be matched on the alveolar-capillary level, and the Image not available. for the whole lung is really of interest only as an approximation of the situation in all the alveolar-capillary units of the lung. For instance, suppose that all 5 L/min of the cardiac output went to the left lung and all 5 L/min of alveolar ventilation went to the right lung. The whole lung Image not available. would be 1.0, but there would be no gas exchange because there could be no gas diffusion between the ventilated alveoli and the perfused pulmonary capillaries.
Oxygen is delivered to the alveolus by alveolar ventilation, is removed from the alveolus as it diffuses into the pulmonary capillary blood, and is carried away by blood flow. Similarly, carbon dioxide is delivered to the alveolus in the mixed venous blood and diffuses into the alveolus in the pulmonary capillary. The carbon dioxide is removed from the alveolus by alveolar ventilation. As will be discussed in Chapter 6, at resting cardiac outputs the diffusion of both oxygen and carbon dioxide is normally limited by pulmonary perfusion. Thus, the alveolar partial pressures of both oxygen and carbon dioxide are determined by the Image not available. If the Image not available. in an alveolar-capillary unit increases, the delivery of oxygen relative to its removal will increase, as will the removal ...
Inspiratory Muscle Training or Respiratory Muscle Training or Ventilatory Muscle Training. IMT is the physiotherapy technique, with the help of different breathing exercises.
Gas exchange between the alveoli and the pulmonary capillary blood occurs by diffusion, as will be discussed in the next chapter. Diffusion of oxygen and carbon dioxide occurs passively, according to their concentration differences across the alveolar-capillary barrier. These concentration differences must be maintained by ventilation of the alveoli and perfusion of the pulmonary capillaries.
Alveolar ventilation brings oxygen into the lung and removes carbon dioxide from it. Similarly, the mixed venous blood brings carbon dioxide into the lung and takes up alveolar oxygen. The alveolar Image not available. and Image not available. are thus determined by the relationship between alveolar ventilation and pulmonary capillary perfusion. Alterations in the ratio of ventilation to perfusion, called the Image not available., will result in changes in the alveolar Image not available. and Image not available., as well as in gas delivery to or removal from the lung.
Alveolar ventilation is normally about 4 to 6 L/min and pulmonary blood flow (which is equal to cardiac output) has a similar range, and so the Image not available. for the whole lung is in the range of 0.8 to 1.2. Image not available. However, ventilation and perfusion must be matched on the alveolar-capillary level, and the Image not available. for the whole lung is really of interest only as an approximation of the situation in all the alveolar-capillary units of the lung. For instance, suppose that all 5 L/min of the cardiac output went to the left lung and all 5 L/min of alveolar ventilation went to the right lung. The whole lung Image not available. would be 1.0, but there would be no gas exchange because there could be no gas diffusion between the ventilated alveoli and the perfused pulmonary capillaries.
Oxygen is delivered to the alveolus by alveolar ventilation, is removed from the alveolus as it diffuses into the pulmonary capillary blood, and is carried away by blood flow. Similarly, carbon dioxide is delivered to the alveolus in the mixed venous blood and diffuses into the alveolus in the pulmonary capillary. The carbon dioxide is removed from the alveolus by alveolar ventilation. As will be discussed in Chapter 6, at resting cardiac outputs the diffusion of both oxygen and carbon dioxide is normally limited by pulmonary perfusion. Thus, the alveolar partial pressures of both oxygen and carbon dioxide are determined by the Image not available. If the Image not available. in an alveolar-capillary unit increases, the delivery of oxygen relative to its removal will increase, as will the removal ...
Inspiratory Muscle Training or Respiratory Muscle Training or Ventilatory Muscle Training. IMT is the physiotherapy technique, with the help of different breathing exercises.
Managing Respiratory Symptoms in Advanced MS by Rachael Mosesmiranda olding
Advanced MS & neuromuscular disease cause respiratory problems leading to problems with talking, eating and chest infections, which can be fatal. Rebreathe bags & airway clearance machines / cough machines can enhance quality of life, and prove cost-effective in preventing unplannned hospital admissions for chest infection.
Predictors of weaning from mechanical ventilator outcomeMuhammad Asim Rana
This is a very useful presentation for respiratory therapists and ICU and Emergency physicians. Intended to teach how to assess you patient's readiness for weaning from mechanical ventilator and successful separation from machine.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. •Dyspnea is the main symptom perceived by patients affected by
chronic respiratory diseases. It derives from a complex interaction
of signals arising in the central nervous system, which is connected
through afferent pathway receptors to the peripheral respiratory
system.
•The main goal of rehabilitation is to improve dyspnea; hence,
quantifying dyspnea through specific tools (scales) is essential in
order to describe the level of chronic disability and to assess
eventual changes after intervention.
•In the field of cardiopulmonary disease, the five descriptive
clusters in the language of dyspnea most frequently selected are:
1. chest tightness
2. increased effort of breathing
3. unsatisfied inspiratory effort
4.rapid or superficial breathing
5.breathlessness
3. •The sensation of 'chest tightness', frequently reported by asthmatic
patients during acute bronchial obstruction, may derive from the
stimulation of the pulmonary sensory receptors through vagal and
autonomous pathways these slow adapting receptors, excited by the
contraction of the airway muscle fibers, together with receptors from
irritation (fast adapting) and C fibers could respond to the local
airways inflammation.
•The cluster 'increased work or effort of breathing' includes instead
descriptors often selected in conditions of increased mechanical load,
such as occurs in COPD and in interstitial or neuromuscular diseases.
The work/effort element, inadequate due to respiratory muscle fatigue
or such as occurs during physical exercise, provokes an increase of
the 'corollary discharge' (central motor command to the sensitive
cortex through small, highly localized interneurones in the central
nervous system, that function as sensory receptors).
4. •Unsatisfied inspiratory effort' is a cluster that refers to conditions in
which there is a disparity between central respiratory output and
mechanical response of the respiratory system and it is considered to
play a fundamental role in the increased perception of dyspnea during
physical exercise in patients affected by COPD and interstitial
diseases
•Rapid or shallow breathing' is the respiratory cluster referred as a
transitory experience by normal subjects during intense physical
exercise or in the presence of external chest restriction ; it
characterizes, in pathological terms, the response to exercise of
patients with interstitial diseases.
•'Breathlessness', is a cluster that tends often to be associated to
patients affected by congestive heart failure or other
pathophysiological conditions (pregnancy, physical exercise, COPD).
This dyspnea cluster is characterized by an increased respiratory
drive, usually associated to increased ventilation
5. Borg scale OR rate of perceived exertion(PRE)
•a widely used and reliable indicator to monitor and guide
exercise intensity
•allows individuals to subjectively rate their level of
exertion during exercise or exercise testing (American
College of Sports Medicine, 2010)
•Developed by Gunnar Borg, it is often also referred to as
the Borg Scale(1998)
•Consists of 2 categories
1. the original Borg scale or category scale (6 to 20 scale),
and
2. the revised category-ratio scale (0 to 10 scale). Also
called modified borg scale
6. The original scale was developed in healthy individuals to correlate
with exercise heart rates (e.g., RPE 15 would approximate a HR of
150 bpm), considering the normal resting HR at 60bpm and 10 beats
for each level of exertion .
The category ratio scale was later developed and has since also been
modified to more specifically record symptomatic breathlessness
(Modified Borg Dyspnoea Scale).
7. mMRC(modified medical research council)
•The dyspnoea scale has been in use for many years for grading the
effect of breathlessness on daily activities.
•This scale measures perceived respiratory disability, The MRC
dyspnoea scale is simple to administer as it allows the patients to
indicate the extent to which their breathlessness affects their mobility.
•The 1-5 stage scale is used alongside the questionnaire to establish
clinical grades of breathlessness.
•The questionnaire was first published in 1960 under the approval of
the MRC Committee on the Aetiology of Chronic Bronchitis. This was
revised and a new version published in 1966. When the committee
disbanded, the responsibility for it was passed to the newly formed
MRC Committee for Research into Chronic Bronchitis who again
revised it in 1976
•The currently used scale was last modified on 1986.
8.
9. Usefulness of mMRC
•Researchers such as Bestall et al. have explored its validity in this
context. They found that the scale was a simple and valid method
which could be used to categorize patients with chronic obstructive
pulmonary disease (COPD) in terms of their disability and it could
be used to complement forced expiratory volume in 1 s (FEV1) in
the classification of the severity of disease.
•While much of the recent use of the MRC dyspnoea scale is in
COPD patients, its performance in patients with idiopathic
pulmonary fibrosis and sarcoidosis has also been documented.
• The original MRC breathlessness scale is currently recommended
for use in the diagnosis of patients with COPD by government
bodies such as NICE (National Institute for Health and Care
Excellence in England) and the modified version is a key feature of
the GOLD 2011 (Global Initiative for Chronic Obstructive Airways
Disease) recommend ations on assessment.
10. PR and reduction of dyspnea :
Various mechanisms why which PR reduce the dyspnea
•Reduce metablic load and improve overall muscle function
•Reduce Ventilatory Impedance by
Reducing/counterbalance hyperinflation
Reducing resistive load
•Decrease central drive and desensitization effect
According to ATS guidelines MCID value for modified
borg scale is 1 unit in case of COPD patient